MX2023011649A - Suspension que contiene derivado de heterociclidenacetamida. - Google Patents
Suspension que contiene derivado de heterociclidenacetamida.Info
- Publication number
- MX2023011649A MX2023011649A MX2023011649A MX2023011649A MX2023011649A MX 2023011649 A MX2023011649 A MX 2023011649A MX 2023011649 A MX2023011649 A MX 2023011649A MX 2023011649 A MX2023011649 A MX 2023011649A MX 2023011649 A MX2023011649 A MX 2023011649A
- Authority
- MX
- Mexico
- Prior art keywords
- suspension containing
- acetamide derivative
- heterocyclidene
- heterocyclidene acetamide
- trifluoromethylchroman
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021057713 | 2021-03-30 | ||
| PCT/JP2022/015691 WO2022210784A1 (ja) | 2021-03-30 | 2022-03-29 | ヘテロシクリデンアセトアミド誘導体含有懸濁液 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023011649A true MX2023011649A (es) | 2023-10-11 |
Family
ID=83459508
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023011649A MX2023011649A (es) | 2021-03-30 | 2022-03-29 | Suspension que contiene derivado de heterociclidenacetamida. |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US12564553B2 (https=) |
| EP (1) | EP4316485A4 (https=) |
| JP (3) | JP7175431B1 (https=) |
| KR (1) | KR20230163502A (https=) |
| CN (1) | CN117120048A (https=) |
| AU (1) | AU2022250028A1 (https=) |
| BR (1) | BR112023019820A2 (https=) |
| CA (1) | CA3215750A1 (https=) |
| MX (1) | MX2023011649A (https=) |
| WO (1) | WO2022210784A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3262434A1 (en) | 2022-07-20 | 2025-06-12 | Asahi Kasei Kabushiki Kaisha | Hyaluronic acid derivative drug composition and drug composition |
| WO2025206172A1 (ja) * | 2024-03-28 | 2025-10-02 | 千寿製薬株式会社 | 電子線滅菌処理したヘテロシクリデンアセトアミド誘導体含有組成物 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61164725A (ja) | 1985-01-11 | 1986-07-25 | Inoue Japax Res Inc | ワイヤ電極案内 |
| JPH07304663A (ja) * | 1994-03-18 | 1995-11-21 | Senju Pharmaceut Co Ltd | 眼圧降下用点眼剤 |
| EP0686393B1 (en) | 1994-03-18 | 1998-05-20 | Senju Pharmaceutical Co., Ltd. | Ophthalmic preparations containing sarpogrelate for reducing intraocular pressure |
| JP3402195B2 (ja) * | 1997-05-14 | 2003-04-28 | 千寿製薬株式会社 | 再分散性の良い水性懸濁液剤 |
| WO1998051281A1 (en) | 1997-05-14 | 1998-11-19 | Senju Pharmaceutical Co., Ltd. | Aqueous suspension preparations with excellent redispersibility |
| NZ565080A (en) | 2005-07-22 | 2011-03-31 | Mochida Pharm Co Ltd | Novel heterocyclidene acetamide derivative |
| WO2008123396A1 (ja) * | 2007-03-29 | 2008-10-16 | Santen Pharmaceutical Co., Ltd. | フルオロメトロンを含有する懸濁型点眼剤 |
| ES2493641T3 (es) * | 2007-06-28 | 2014-09-12 | Cydex Pharmaceuticals, Inc. | Administración nasal de soluciones acuosas de corticosteroides |
| JP6230743B1 (ja) * | 2017-05-31 | 2017-11-15 | 持田製薬株式会社 | ヘテロシクリデンアセトアミド誘導体の結晶 |
| WO2021039023A1 (ja) | 2019-08-23 | 2021-03-04 | 持田製薬株式会社 | ヘテロシクリデンアセトアミド誘導体の製造方法 |
| CN112409191A (zh) | 2019-08-23 | 2021-02-26 | 持田制药株式会社 | 光学活性的氨基醇的制备方法 |
| JP6966667B2 (ja) * | 2019-08-27 | 2021-11-17 | 参天製薬株式会社 | ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物 |
| JP7419728B2 (ja) | 2019-09-27 | 2024-01-23 | ブラザー工業株式会社 | 通信装置と通信装置のためのコンピュータプログラム |
| MY207759A (en) | 2019-10-04 | 2025-03-17 | Mochida Pharm Co Ltd | Pharmaceutical drug containing heterocyclidene acetamide derivative |
-
2022
- 2022-03-29 CA CA3215750A patent/CA3215750A1/en active Pending
- 2022-03-29 WO PCT/JP2022/015691 patent/WO2022210784A1/ja not_active Ceased
- 2022-03-29 JP JP2022546133A patent/JP7175431B1/ja active Active
- 2022-03-29 CN CN202280026310.3A patent/CN117120048A/zh active Pending
- 2022-03-29 EP EP22780995.1A patent/EP4316485A4/en active Pending
- 2022-03-29 AU AU2022250028A patent/AU2022250028A1/en active Pending
- 2022-03-29 US US18/553,141 patent/US12564553B2/en active Active
- 2022-03-29 MX MX2023011649A patent/MX2023011649A/es unknown
- 2022-03-29 BR BR112023019820A patent/BR112023019820A2/pt unknown
- 2022-03-29 KR KR1020237037161A patent/KR20230163502A/ko active Pending
- 2022-11-08 JP JP2022178888A patent/JP7273235B2/ja active Active
-
2023
- 2023-04-27 JP JP2023073689A patent/JP2023099107A/ja active Pending
-
2025
- 2025-01-03 US US19/009,331 patent/US12527740B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA3215750A1 (en) | 2022-10-06 |
| US20240180827A1 (en) | 2024-06-06 |
| JP2023099107A (ja) | 2023-07-11 |
| US12527740B2 (en) | 2026-01-20 |
| JPWO2022210784A1 (https=) | 2022-10-06 |
| AU2022250028A1 (en) | 2023-11-16 |
| US20250134808A1 (en) | 2025-05-01 |
| JP7175431B1 (ja) | 2022-11-18 |
| KR20230163502A (ko) | 2023-11-30 |
| JP2023011898A (ja) | 2023-01-24 |
| EP4316485A4 (en) | 2025-03-26 |
| BR112023019820A2 (pt) | 2023-11-07 |
| WO2022210784A1 (ja) | 2022-10-06 |
| EP4316485A1 (en) | 2024-02-07 |
| JP7273235B2 (ja) | 2023-05-12 |
| CN117120048A (zh) | 2023-11-24 |
| US12564553B2 (en) | 2026-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2023011649A (es) | Suspension que contiene derivado de heterociclidenacetamida. | |
| WO2017158365A3 (en) | Ophthalmic delivery device and ophthalmic active agent containing compositions | |
| CL2020002252A1 (es) | Formulación oftálmica. | |
| EP3569601A3 (en) | N-(phenylsulfonyl)benzamides and related compounds as bcl-2 inhibitors | |
| DE60315322D1 (de) | Zusammensetzungen mit verbesserter antimikrobieller wirksamkeit gegen acanthamoebae | |
| MX2025005474A (es) | Farmaco farmaceutico que contiene derivado de heterocicliden acetamida | |
| AU2019339740A8 (en) | CSF-1R antibody formulation | |
| MXPA06014470A (es) | Formulaciones oftalmicas que incluyen antagonistas de alfa 1 selectivas. | |
| EP3545857A3 (en) | Lateral access retractor and core insertion | |
| WO2020061249A3 (en) | Artificial tear, contact lens and drug vehicle compositions and methods of use thereof | |
| CL2020002838A1 (es) | Suspensión acuosa concentrada en cápsulas que contiene un protector de herbicidas y un agente plaguicida | |
| MX2020004962A (es) | Preparacion de liberacion controlada. | |
| PH12021551412A1 (en) | Ursodeoxycholic acid-containing agent for treating or preventing presbyopia | |
| MX2022013373A (es) | Composicion de herbicida de sulfonilurea liquida. | |
| MX352311B (es) | Jabones líquidos para manos y geles de ducha. | |
| ZA200709296B (en) | Ophthalmic suspension comprising an ophthalmic drug, a poloxamine and a glycolotonicity-adjusting agent, use of said composition for the manufacture of a medicament for treating ophthalmic disorders | |
| MX2018010161A (es) | Una manga desechable que tiene propiedad antimicrobiana para cubrir un brazo de un par de gafas. | |
| MX2025003326A (es) | Suspension esterilizada que contiene un derivado de heterociclideno acetamida | |
| PH12019502335A1 (en) | Thermo-responsive gelling artificial lacrima | |
| MX2023002352A (es) | Formulaciones de un inhibidor de mcl-1. | |
| PH12020551194A1 (en) | Eye drops in form of solution comprising benzopyran derivative or pharmaceutically acceptable salt thereof | |
| EP3773611A4 (en) | OMNIPHILE NANOVESICLES BASED ON MODIFIED POLYSACCHARIDES FOR ACTIVE INGREDIENT DELIVERY | |
| MX2020013472A (es) | Estabilizador y metodo de fabricacion del mismo. | |
| UY39758A (es) | Formulación de sotorasib | |
| WO2020247565A8 (en) | Oral care composition |